Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
PowerPoint slides
Rights and permissions
About this article
Cite this article
Yip, A., Webster, R. The market for chimeric antigen receptor T cell therapies. Nat Rev Drug Discov 17, 161–162 (2018). https://doi.org/10.1038/nrd.2017.266
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2017.266
- Springer Nature Limited
This article is cited by
-
CAR T cells: engineered immune cells to treat brain cancers and beyond
Molecular Cancer (2023)
-
Targeted modulation of immune cells and tissues using engineered biomaterials
Nature Reviews Bioengineering (2023)
-
Applications of synthetic biology in medical and pharmaceutical fields
Signal Transduction and Targeted Therapy (2023)
-
Overview of the pre-clinical and clinical studies about the use of CAR-T cell therapy of cancer combined with oncolytic viruses
World Journal of Surgical Oncology (2022)
-
Engineered cells as glioblastoma therapeutics
Cancer Gene Therapy (2022)